Pages that link to "Q57779762"
Jump to navigation
Jump to search
The following pages link to Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes (Q57779762):
Displaying 50 items.
- Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics (Q24616751) (← links)
- Advances and Challenges of Liposome Assisted Drug Delivery (Q26773160) (← links)
- Drug carriers based on highly protein-resistant materials for prolonged in vivo circulation time (Q26774341) (← links)
- Anti-PEG immunity: emergence, characteristics, and unaddressed questions (Q26825556) (← links)
- Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm (Q27026630) (← links)
- Lipid-Based Nanocarriers for RNA Delivery (Q28080706) (← links)
- Drug Carriers: Not an Innocent Delivery Man (Q28082414) (← links)
- Using exosomes, naturally-equipped nanocarriers, for drug delivery (Q28265872) (← links)
- Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine (Q28391849) (← links)
- Assembly of bio-nanoparticles for double controlled drug release (Q28536927) (← links)
- Self-assembled 20-nm (64)Cu-micelles enhance accumulation in rat glioblastoma (Q28603646) (← links)
- Designer lipids for drug delivery: from heads to tails (Q30402374) (← links)
- Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting (Q30456053) (← links)
- Emerging Role of the Spleen in the Pharmacokinetics of Monoclonal Antibodies, Nanoparticles and Exosomes (Q33838871) (← links)
- Effect of repetitive administration of Doxorubicin-containing liposomes on plasma pharmacokinetics and drug biodistribution in a rat brain tumor model. (Q33906751) (← links)
- Tolerance-like innate immunity and spleen injury: a novel discovery via the weekly administrations and consecutive injections of PEGylated emulsions (Q34028188) (← links)
- Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles (Q34079604) (← links)
- Liposomal encapsulation enhances and prolongs the anti-inflammatory effects of water-soluble dexamethasone phosphate in experimental adjuvant arthritis (Q34153033) (← links)
- Recognition by macrophages and liver cells of opsonized phospholipid vesicles and phospholipid headgroups. (Q34240585) (← links)
- Nanomedicine--challenge and perspectives (Q34247073) (← links)
- Effects of a novel pH-sensitive liposome with cleavable esterase-catalyzed and pH-responsive double smart mPEG lipid derivative on ABC phenomenon (Q35234736) (← links)
- Exosomes as drug delivery vehicles for Parkinson's disease therapy (Q35602589) (← links)
- Accelerated blood clearance phenomenon upon cross-administration of PEGylated nanocarriers in beagle dogs (Q35624235) (← links)
- The effect of polymer backbone chemistry on the induction of the accelerated blood clearance in polymer modified liposomes (Q35669424) (← links)
- Repeated injection of PEGylated solid lipid nanoparticles induces accelerated blood clearance in mice and beagles (Q36058748) (← links)
- Application of poly(ethylene glycol)-distearoylphosphatidylethanolamine (PEG-DSPE) block copolymers and their derivatives as nanomaterials in drug delivery (Q36161132) (← links)
- Pharmacokinetics and antitumor efficacy of DSPE-PEG2000 polymeric liposomes loaded with quercetin and temozolomide: Analysis of their effectiveness in enhancing the chemosensitization of drug-resistant glioma cells (Q36630698) (← links)
- PEGylation as a strategy for improving nanoparticle-based drug and gene delivery (Q36703361) (← links)
- Understanding the immunogenicity and antigenicity of nanomaterials: Past, present and future (Q36739647) (← links)
- Accelerated drug release and clearance of PEGylated epirubicin liposomes following repeated injections: a new challenge for sequential low-dose chemotherapy (Q36740474) (← links)
- Using the Power of Organic Synthesis for Engineering the Interactions of Nanoparticles with Biological Systems (Q36844202) (← links)
- Nanoparticle characterization: state of the art, challenges, and emerging technologies. (Q36901928) (← links)
- Nanovehicular intracellular delivery systems (Q37058812) (← links)
- Accelerated Blood Clearance Phenomenon Reduces the Passive Targeting of PEGylated Nanoparticles in Peripheral Arterial Disease (Q37123107) (← links)
- A unique squalenoylated and nonpegylated doxorubicin nanomedicine with systemic long-circulating properties and anticancer activity (Q37495209) (← links)
- Advanced Strategies in Immune Modulation of Cancer Using Lipid-Based Nanoparticles (Q37625459) (← links)
- Clinical developments in nanotechnology for cancer therapy (Q37765187) (← links)
- Recent advances in stealth coating of nanoparticle drug delivery systems (Q37974590) (← links)
- Gemcitabine-loaded liposomes: rationale, potentialities and future perspectives. (Q38058785) (← links)
- The immunogenicity of polyethylene glycol: facts and fiction (Q38106847) (← links)
- Challenging the future of siRNA therapeutics against cancer: the crucial role of nanotechnology (Q38162098) (← links)
- RETRACTED: Recent trends of polymer mediated liposomal gene delivery system. (Q38253654) (← links)
- Lipid nanoparticles for gene delivery (Q38269555) (← links)
- Nanobiotechnology for the Therapeutic Targeting of Cancer Cells in Blood (Q38387142) (← links)
- Assessing the effect of a nude mouse model on nanoparticle-mediated gene delivery (Q38750076) (← links)
- Nanomedicines for renal disease: current status and future applications (Q38802375) (← links)
- Anti-Tumor Effects of Bak-Proteoliposomes against Glioblastoma. (Q38837839) (← links)
- Biodistribution, tumor uptake and efficacy of 5-FU-loaded liposomes: why size matters (Q39002313) (← links)
- Lipid Nanovectors to Deliver RNA Oligonucleotides in Cancer (Q39196485) (← links)
- Near-infrared image-guided delivery and controlled release using optimized thermosensitive liposomes (Q39373421) (← links)